BIOMAT Database Logo BIOMAT Database Logo

Acetylene compounds of potential pharmacological value. XII. Central and peripheral anticholinergic activity of t-aminoalkynyl esters of some carboxylic acids. 1969

R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D011680 Pupil The aperture in the iris through which light passes. Pupils
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003509 Cyclohexanecarboxylic Acids Carboxylic acid derivatives of cyclohexane. Acids, Cyclohexanecarboxylic

Related Publications

R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. XIV. N-(t-aminoalkynyl)-substituted succinimides and maleimides. A class of central anticholinergic agents.
July 1970, Journal of medicinal chemistry,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. XX. N-(t-aminoalkynyl)substituted phthalimides.
January 1975, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. X. Some t-aminoalkynyl derivatives of indole, 3,4,5-trimethoxybenzene and quinuclidine.
February 1968, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
December 1973, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.
January 1975, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. VI. Some amides of 3,4,5-trimethoxyphenylpropiolic acid.
February 1966, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. XL. N-(tert-aminoalkynyl)-substituted 3-isothiazolidinone-1,1-dioxides and tetrahydro-1,2-thiazin-3-one-1,1-dioxides.
January 1987, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. IX. N-(4-dialkylamino-2-butynyl)-substituted carboxylic and sulphonic acid amides.
September 1967, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
January 1975, Acta pharmaceutica Suecica,
R Dahlbom, and B Erbing, and K Olsson, and R George, and D J Jenden
Acetylene compounds of potential pharmacological value. 13. 2-substituted 1,3-indandiones.
June 1969, Acta pharmaceutica Suecica,
Copied contents to your clipboard!